SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17709660
Source:
http://linkedlifedata.com/resource/pubmed/id/17709660
Search
Subject
(
50
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0031765
,
umls-concept:C0033860
,
umls-concept:C0449297
,
umls-concept:C0962603
pubmed:issue
8
pubmed:dateCreated
2007-8-21
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00407342
pubmed:abstractText
To determine whether the addition of 311-nm narrowband UV-B (NB UV-B) phototherapy accelerates and improves the therapeutic efficacy of alefacept, a biological antipsoriatic drug approved for the treatment of moderate to severe psoriasis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17709660-18711092
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372433
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Dermatologic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/alefacept
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0003-987X
pubmed:author
pubmed-author:HoferAngelikaA
,
pubmed-author:KerlHelmutH
,
pubmed-author:LegatFranz JFJ
,
pubmed-author:QuehenbergerFranzF
,
pubmed-author:SalmhoferWolfgangW
,
pubmed-author:WackernagelAlexandraA
,
pubmed-author:WolfPeterP
pubmed:issnType
Print
pubmed:volume
143
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1016-22
pubmed:dateRevised
2008-9-11
pubmed:meshHeading
pubmed-meshheading:17709660-Adult
,
pubmed-meshheading:17709660-Combined Modality Therapy
,
pubmed-meshheading:17709660-Dermatologic Agents
,
pubmed-meshheading:17709660-Female
,
pubmed-meshheading:17709660-Follow-Up Studies
,
pubmed-meshheading:17709660-Humans
,
pubmed-meshheading:17709660-Male
,
pubmed-meshheading:17709660-Middle Aged
,
pubmed-meshheading:17709660-Prospective Studies
,
pubmed-meshheading:17709660-Psoriasis
,
pubmed-meshheading:17709660-Recombinant Fusion Proteins
,
pubmed-meshheading:17709660-Treatment Outcome
,
pubmed-meshheading:17709660-Ultraviolet Therapy
pubmed:year
2007
pubmed:articleTitle
Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis.
pubmed:affiliation
Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, A-8036 Graz, Austria.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial